SVAS BIOSANA SPA (SVS.MI) Fundamental Analysis & Valuation

BIT:SVS • IT0005469264

8.84 EUR
+0.32 (+3.76%)
Last: Feb 16, 2026, 07:00 PM

This SVS.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

Overall SVS gets a fundamental rating of 6 out of 10. We evaluated SVS against 65 industry peers in the Health Care Equipment & Supplies industry. SVS has an average financial health and profitability rating. SVS has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination!


Dividend Valuation Growth Profitability Health

5

1. SVS.MI Profitability Analysis

1.1 Basic Checks

  • In the past year SVS was profitable.
  • In the past year SVS has reported a negative cash flow from operations.
  • SVS had positive earnings in each of the past 5 years.
  • In the past 5 years SVS always reported a positive cash flow from operatings.
SVS.MI Yearly Net Income VS EBIT VS OCF VS FCFSVS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M 8M 10M

1.2 Ratios

  • SVS has a Return On Assets (3.75%) which is comparable to the rest of the industry.
  • With a decent Return On Equity value of 10.43%, SVS is doing good in the industry, outperforming 69.23% of the companies in the same industry.
  • The Return On Invested Capital of SVS (8.04%) is better than 66.15% of its industry peers.
  • SVS had an Average Return On Invested Capital over the past 3 years of 6.63%. This is below the industry average of 10.72%.
  • The 3 year average ROIC (6.63%) for SVS is below the current ROIC(8.04%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.75%
ROE 10.43%
ROIC 8.04%
ROA(3y)3.03%
ROA(5y)2.75%
ROE(3y)8.2%
ROE(5y)7.97%
ROIC(3y)6.63%
ROIC(5y)6.34%
SVS.MI Yearly ROA, ROE, ROICSVS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • SVS has a Profit Margin of 5.09%. This is comparable to the rest of the industry: SVS outperforms 49.23% of its industry peers.
  • In the last couple of years the Profit Margin of SVS has grown nicely.
  • SVS has a Operating Margin of 8.71%. This is comparable to the rest of the industry: SVS outperforms 44.62% of its industry peers.
  • SVS's Operating Margin has improved in the last couple of years.
  • SVS's Gross Margin of 26.17% is on the low side compared to the rest of the industry. SVS is outperformed by 87.69% of its industry peers.
  • In the last couple of years the Gross Margin of SVS has declined.
Industry RankSector Rank
OM 8.71%
PM (TTM) 5.09%
GM 26.17%
OM growth 3Y3.27%
OM growth 5Y3.94%
PM growth 3Y7.81%
PM growth 5Y7.66%
GM growth 3Y-3.21%
GM growth 5Y-2.88%
SVS.MI Yearly Profit, Operating, Gross MarginsSVS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. SVS.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SVS is creating some value.
  • Compared to 1 year ago, SVS has less shares outstanding
  • SVS has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for SVS has been reduced compared to a year ago.
SVS.MI Yearly Shares OutstandingSVS.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
SVS.MI Yearly Total Debt VS Total AssetsSVS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • SVS has an Altman-Z score of 1.82. This is not the best score and indicates that SVS is in the grey zone with still only limited risk for bankruptcy at the moment.
  • SVS has a worse Altman-Z score (1.82) than 67.69% of its industry peers.
  • SVS has a Debt/Equity ratio of 0.62. This is a neutral value indicating SVS is somewhat dependend on debt financing.
  • SVS has a worse Debt to Equity ratio (0.62) than 67.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Altman-Z 1.82
ROIC/WACC1.14
WACC7.08%
SVS.MI Yearly LT Debt VS Equity VS FCFSVS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 1.82 indicates that SVS should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.82, SVS perfoms like the industry average, outperforming 56.92% of the companies in the same industry.
  • A Quick Ratio of 1.34 indicates that SVS should not have too much problems paying its short term obligations.
  • SVS's Quick ratio of 1.34 is fine compared to the rest of the industry. SVS outperforms 63.08% of its industry peers.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.34
SVS.MI Yearly Current Assets VS Current LiabilitesSVS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

7

3. SVS.MI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 24.41% over the past year.
  • Measured over the past years, SVS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 19.97% on average per year.
  • SVS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.07%.
  • Measured over the past years, SVS shows a quite strong growth in Revenue. The Revenue has been growing by 10.34% on average per year.
EPS 1Y (TTM)24.41%
EPS 3Y23.97%
EPS 5Y19.97%
EPS Q2Q%34.09%
Revenue 1Y (TTM)9.07%
Revenue growth 3Y14.06%
Revenue growth 5Y10.34%
Sales Q2Q%21.03%

3.2 Future

  • Based on estimates for the next years, SVS will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.83% on average per year.
  • The Revenue is expected to grow by 9.07% on average over the next years. This is quite good.
EPS Next Y33.33%
EPS Next 2Y17.92%
EPS Next 3Y14.83%
EPS Next 5YN/A
Revenue Next Year19.23%
Revenue Next 2Y11.86%
Revenue Next 3Y9.07%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SVS.MI Yearly Revenue VS EstimatesSVS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
SVS.MI Yearly EPS VS EstimatesSVS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

7

4. SVS.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • SVS is valuated cheaply with a Price/Earnings ratio of 6.96.
  • Compared to the rest of the industry, the Price/Earnings ratio of SVS indicates a rather cheap valuation: SVS is cheaper than 100.00% of the companies listed in the same industry.
  • SVS is valuated cheaply when we compare the Price/Earnings ratio to 26.25, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 5.99, which indicates a rather cheap valuation of SVS.
  • Based on the Price/Forward Earnings ratio, SVS is valued cheaply inside the industry as 95.38% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of SVS to the average of the S&P500 Index (24.39), we can say SVS is valued rather cheaply.
Industry RankSector Rank
PE 6.96
Fwd PE 5.99
SVS.MI Price Earnings VS Forward Price EarningsSVS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SVS is valued cheaply inside the industry as 93.85% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.76
SVS.MI Per share dataSVS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • SVS's earnings are expected to grow with 14.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.21
PEG (5Y)0.35
EPS Next 2Y17.92%
EPS Next 3Y14.83%

6

5. SVS.MI Dividend Analysis

5.1 Amount

  • SVS has a Yearly Dividend Yield of 2.78%.
  • SVS's Dividend Yield is rather good when compared to the industry average which is at 1.01. SVS pays more dividend than 87.69% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, SVS pays a better dividend.
Industry RankSector Rank
Dividend Yield 2.78%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • SVS pays out 19.64% of its income as dividend. This is a sustainable payout ratio.
DP19.64%
EPS Next 2Y17.92%
EPS Next 3Y14.83%
SVS.MI Yearly Income VS Free CF VS DividendSVS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M
SVS.MI Dividend Payout.SVS.MI Dividend Payout, showing the Payout Ratio.SVS.MI Dividend Payout.PayoutRetained Earnings

SVS.MI Fundamentals: All Metrics, Ratios and Statistics

SVAS BIOSANA SPA

BIT:SVS (2/16/2026, 7:00:00 PM)

8.84

+0.32 (+3.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners5.58%
Inst Owner ChangeN/A
Ins Owners64.79%
Ins Owner ChangeN/A
Market Cap49.50M
Revenue(TTM)132.55M
Net Income(TTM)6.74M
Analysts80
Price Target17.44 (97.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.78%
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DP19.64%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)15.93%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 6.96
Fwd PE 5.99
P/S 0.37
P/FCF N/A
P/OCF N/A
P/B 0.77
P/tB 1.06
EV/EBITDA 4.76
EPS(TTM)1.27
EY14.37%
EPS(NY)1.47
Fwd EY16.68%
FCF(TTM)-1.21
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS23.67
BVpS11.54
TBVpS8.36
PEG (NY)0.21
PEG (5Y)0.35
Graham Number18.16
Profitability
Industry RankSector Rank
ROA 3.75%
ROE 10.43%
ROCE 10.81%
ROIC 8.04%
ROICexc 10.91%
ROICexgc 14.1%
OM 8.71%
PM (TTM) 5.09%
GM 26.17%
FCFM N/A
ROA(3y)3.03%
ROA(5y)2.75%
ROE(3y)8.2%
ROE(5y)7.97%
ROIC(3y)6.63%
ROIC(5y)6.34%
ROICexc(3y)10.45%
ROICexc(5y)9.43%
ROICexgc(3y)12.81%
ROICexgc(5y)11.57%
ROCE(3y)8.91%
ROCE(5y)8.53%
ROICexgc growth 3Y10.44%
ROICexgc growth 5Y8.61%
ROICexc growth 3Y11.05%
ROICexc growth 5Y7.72%
OM growth 3Y3.27%
OM growth 5Y3.94%
PM growth 3Y7.81%
PM growth 5Y7.66%
GM growth 3Y-3.21%
GM growth 5Y-2.88%
F-Score5
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Debt/EBITDA 2.36
Cap/Depr 113.41%
Cap/Sales 4.68%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.82
Quick Ratio 1.34
Altman-Z 1.82
F-Score5
WACC7.08%
ROIC/WACC1.14
Cap/Depr(3y)111.56%
Cap/Depr(5y)102.51%
Cap/Sales(3y)5.01%
Cap/Sales(5y)4.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.41%
EPS 3Y23.97%
EPS 5Y19.97%
EPS Q2Q%34.09%
EPS Next Y33.33%
EPS Next 2Y17.92%
EPS Next 3Y14.83%
EPS Next 5YN/A
Revenue 1Y (TTM)9.07%
Revenue growth 3Y14.06%
Revenue growth 5Y10.34%
Sales Q2Q%21.03%
Revenue Next Year19.23%
Revenue Next 2Y11.86%
Revenue Next 3Y9.07%
Revenue Next 5YN/A
EBIT growth 1Y17.64%
EBIT growth 3Y17.79%
EBIT growth 5Y14.69%
EBIT Next Year94.24%
EBIT Next 3Y29.1%
EBIT Next 5YN/A
FCF growth 1Y-245.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-105.92%
OCF growth 3Y26.58%
OCF growth 5Y-3.68%

SVAS BIOSANA SPA / SVS.MI FAQ

What is the ChartMill fundamental rating of SVAS BIOSANA SPA (SVS.MI) stock?

ChartMill assigns a fundamental rating of 6 / 10 to SVS.MI.


Can you provide the valuation status for SVAS BIOSANA SPA?

ChartMill assigns a valuation rating of 7 / 10 to SVAS BIOSANA SPA (SVS.MI). This can be considered as Undervalued.


How profitable is SVAS BIOSANA SPA (SVS.MI) stock?

SVAS BIOSANA SPA (SVS.MI) has a profitability rating of 5 / 10.


What are the PE and PB ratios of SVAS BIOSANA SPA (SVS.MI) stock?

The Price/Earnings (PE) ratio for SVAS BIOSANA SPA (SVS.MI) is 6.96 and the Price/Book (PB) ratio is 0.77.


Is the dividend of SVAS BIOSANA SPA sustainable?

The dividend rating of SVAS BIOSANA SPA (SVS.MI) is 6 / 10 and the dividend payout ratio is 19.64%.